Marina Biotech, Inc. MRNA Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Marina Biotech, Inc. MRNA Company Overview 

Stock Message Board http://investorshangout.com/search?q=MRNA&...mp;yt1=Go!

Marina Biotech, Inc. MRNA Current Price and Quotes
0.264
Previous Close
0.264
Open
0.264

Daily Range
0.264 - 0.264
52wk Range
0.70 - 0.18

Volume
775
Dividend
N/A

Average Vol (3m)
21,325
Yield
N/A

Marina Biotech, Inc. MRNA
Company Information
3830 Monte Villa Parkway
Bothell, WA 98021

Website: http://www.marinabio.com
Phone: 425-908-3600

Marina Biotech, Inc. MRNA
Marina Biotech is a biotechnology company focused on the development and commercialization of oligonucleotide-based therapeutics utilizing multiple mechanisms of action including RNA interference and messenger RNA translational blocking.

Marina Biotech, Inc. MRNA
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2012 10-Q
CIK 0000737207
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1983
Employees 43 a/o Jan 12, 2012
Company Officers/Contacts
J.Michael French President, CEO
Philip C. Ranker Interim CFO, IR
Company Directors
J.Michael French
Stefan Loren
Joseph Ramelli
Company Notes
Formerly= MDRNA,Inc. until 7-2010
Formerly=Nastech Pharmaceutical Co., Inc. until 6-2008
Service Providers
Auditor/Accountant
KPMG LLP
801 2nd Ave # 900
Seattle, WA, 98104-1515
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Marina Biotech, Inc. MRNA
MRNA Security Details
Share Structure
Market Value1 $4,320,734 a/o Aug 30, 2013
Shares Outstanding 16,366,415 a/o Nov 30, 2012
Float 10,537,184 a/o Jan 23, 2012
Authorized Shares 180,000,000 a/o Jan 23, 2012
Par Value  0.006
Shareholders
Shareholders of Record Not Available
Security Notes
New Issue=3-84 50,000,000 shs in units (1 sh Com, 2 cents Warr 4-27-86 & 4 cents Warr 4-27-86) at 1 cent per unit (best efforts-all or none) by J. Brooks Securities, Inc.
Par Changed=11-9-93 $0.002 to $0.006 Basis: 1 for 3 reverse split
Capital Change=shs decreased by 1 for 4 split Pay date=07/22/2010.
Note = Company delisted from NASDAQ on 02/02/12
Capital Change=shs decreased by 1 for 10 split. Pay date=12/23/2011.
Short Selling Data
Short Interest 281,569 (3.61%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
American Stock Transfer & Trust Company

Marina Biotech, Inc. MRNA Recent News


Aug 14, 2013 Marina Biotech Monetizes UNA Intellectual Property Estate Through Agreement With Arcturus Therapeutics


Marina Biotech, Inc. MRNA Financials
Period Ending Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
Total Revenue 2,236 2,460 14,732 2,609
Cost of Revenue - - - 2,906
Gross Profit 2,236 2,460 14,732 (297)
Operating Expenses
Research and Development 11,438 18,105 14,882 36,771
Sales, General and Admin. 8,369 10,359 10,088 13,617
Non-Recurring Items 17,424 3,526 455 8,257
Other - - - -
Operating Income (34,995) (29,530) (10,693) (58,942)
Income From Continuing Operations
Add'l Income/Expense Items 6,714 4,604 3,185 519
Earnings Before Interest and Tax (28,281) (24,926) (7,508) (58,423)
Interest Expense - 2,827 538 797
Earnings Before Tax (28,281) (27,753) (8,046) (59,220)
Income Tax 1,143 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (29,424) (27,753) (8,046) (59,220)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (29,424) (27,753) (8,046) (59,220)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (29,424) (27,753) (8,046) (59,220)

MRNA Marina Biotech, Inc. Research DD Guide

MRNA Marina Biotech, Inc. Stock Message Board http://investorshangout.com/search?q=MRNA&...mp;yt0=Go!
MRNA Marina Biotech, Inc. Stock Quote http://www.otcmarkets.com/stock/MRNA/quote
MRNA Marina Biotech, Inc. Stock Chart http://www.otcmarkets.com/stock/MRNA/chart
MRNA Marina Biotech, Inc. Company Info http://www.otcmarkets.com/stock/MRNA/company-info
MRNA Marina Biotech, Inc. Recent News http://www.otcmarkets.com/stock/MRNA/news
MRNA Marina Biotech, Inc. Financials http://www.otcmarkets.com/stock/MRNA/financials
MRNA Marina Biotech, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/MRNA/filings
MRNA Marina Biotech, Inc. Short Sales http://www.otcmarkets.com/stock/MRNA/short-sales
MRNA Marina Biotech, Inc. Insider Disclosure http://www.otcmarkets.com/stock/MRNA/insider-transactions
MRNA Marina Biotech, Inc. Research Reports http://www.otcmarkets.com/stock/MRNA/research
MRNA Marina Biotech, Inc. Summary http://finance.yahoo.com/q?s=MRNA
MRNA Marina Biotech, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=MRNA+Historical+Prices
MRNA Marina Biotech, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=MRNA
MRNA Marina Biotech, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=MRNA+Basic+Chart
MRNA Marina Biotech, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=MRNA+Basic+Tech.+Analysis
MRNA Marina Biotech, Inc. Headlines http://finance.yahoo.com/q/h?s=MRNA+Headlines
MRNA Marina Biotech, Inc. Press Releases http://finance.yahoo.com/q/p?s=MRNA+Press+Releases
MRNA Marina Biotech, Inc. Company Profile http://finance.yahoo.com/q/pr?s=MRNA+Profile
MRNA Marina Biotech, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=MRNA+Key+Statistics
MRNA Marina Biotech, Inc. Industry http://finance.yahoo.com/q/in?s=MRNA+Industry
MRNA Marina Biotech, Inc. Major Holders http://finance.yahoo.com/q/mh?s=MRNA+Major+Holders
MRNA Marina Biotech, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=MRNA+Insider+Transactions
MRNA Marina Biotech, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=MRNA+Insider+Roster
MRNA Marina Biotech, Inc. Income Statement http://finance.yahoo.com/q/is?s=MRNA
MRNA Marina Biotech, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=MRNA
MRNA Marina Biotech, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=MRNA+Cash+Flow&annual
MRNA Marina Biotech, Inc. Nasdaq http://www.nasdaq.com/symbol/MRNA
MRNA Marina Biotech, Inc. Market Watch http://www.marketwatch.com/investing/stock/MRNA
MRNA Marina Biotech, Inc. Bloomberg http://www.bloomberg.com/quote/MRNA:US
MRNA Marina Biotech, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=MRNA
MRNA Marina Biotech, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=MRNA
MRNA Marina Biotech, Inc. Barchart http://www.barchart.com/quotes/stocks/MRNA
MRNA Marina Biotech, Inc. OTC Short Report http://otcshortreport.com/index.php?index=MRNA
MRNA Marina Biotech, Inc. Investopedia http://www.investopedia.com/markets/stocks/MRNA/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 88

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 23

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 28

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 160

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
Air Canada-CAE Scholarship Drives Women in Aviation

Updated Category News Views 88

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading